TSE:NWH.UNNorthWest Health Prop Real Est Inv Trust Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NorthWest Health Prop Real Est Inv Trust Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$11.05 0.00 (0.00 %) (As of 07/6/2020 04:00 PM ET) Add Compare Share Today's RangeC$10.97Now: C$11.05▼C$11.1050-Day RangeC$9.25MA: C$10.60▼C$11.7652-Week RangeC$6.27Now: C$11.05▼C$13.35Volume95,066 shsAverage Volume258,541 shsMarket CapitalizationC$1.95 billionP/E Ratio19.39Dividend Yield7.24%BetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendInsider TradesHeadlinesSocial Media NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at March 31, 2019 the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 158 income-producing properties and 11.9 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages over 180 professionals in nine offices in five countries to serve as a long term real estate partner to leading healthcare operators.Read More Beat the Market (BTM) Rank™ 1.3 Analyst's Opinion Consensus RatingNorthWest Health Prop Real Est Inv Trust has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$11.69, NorthWest Health Prop Real Est Inv Trust has a potential upside of 5.8% from its current price of C$11.05.Amount of Analyst CoverageNorthWest Health Prop Real Est Inv Trust has only been the subject of 2 research reports in the past 90 days. Previous Next 1.3 Community Rank Outperform VotesNorthWest Health Prop Real Est Inv Trust has received 109 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNorthWest Health Prop Real Est Inv Trust has received 321 “underperform” votes. (Add your “underperform” vote.)Community SentimentNorthWest Health Prop Real Est Inv Trust has received 74.65% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about NorthWest Health Prop Real Est Inv Trust and other stocks. Vote “Outperform” if you believe NWH.UN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NWH.UN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipNorthWest Health Prop Real Est Inv Trust is a leading dividend payer. It pays a dividend yield of 7.24%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthNorthWest Health Prop Real Est Inv Trust does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of NorthWest Health Prop Real Est Inv Trust is 140.35%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NorthWest Health Prop Real Est Inv Trust insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for NorthWest Health Prop Real Est Inv Trust are expected to decrease by -100.00% in the coming year, from C$0.52 to C$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NorthWest Health Prop Real Est Inv Trust is 19.39, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.68.Price to Earnings Ratio vs. SectorThe P/E ratio of NorthWest Health Prop Real Est Inv Trust is 19.39, which means that it is trading at a more expensive P/E ratio than the Real Estate sector average P/E ratio of about 10.27.Price to Book Value per Share RatioNorthWest Health Prop Real Est Inv Trust has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.3Community Rank: 1.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.84 out of 5 stars Industry, Sector and Symbol Stock Exchange TSE Industry REIT - Healthcare Facilities Sub-IndustryN/A SectorReal Estate Current SymbolTSE:NWH.UN Previous Symbol CUSIPN/A CIKN/A Webwww.nwhp.ca Phone+1-416-3662000Debt Debt-to-Equity Ratio123.09 Current Ratio0.30 Quick Ratio0.23Price-To-Earnings Trailing P/E Ratio19.39 Forward P/E Ratio21.41 P/E GrowthN/A Sales & Book Value Annual SalesC$376.12 million Price / Sales5.18 Cash FlowC$0.55 per share Price / Cash Flow20.20 Book ValueC$8.65 per share Price / Book1.28Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees213 Outstanding Shares176,155,008Market CapC$1.95 billion Next Earnings DateN/A OptionableNot Optionable TSX:NWH.UN Rates by TradingView Receive NWH.UN News and Ratings via Email Sign-up to receive the latest news and ratings for NWH.UN and its competitors with MarketBeat's FREE daily newsletter. NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Frequently Asked Questions How has NorthWest Health Prop Real Est Inv Trust's stock been impacted by COVID-19 (Coronavirus)? NorthWest Health Prop Real Est Inv Trust's stock was trading at C$10.70 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NWH.UN shares have increased by 3.3% and is now trading at C$11.05. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of NorthWest Health Prop Real Est Inv Trust? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NorthWest Health Prop Real Est Inv Trust in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for NorthWest Health Prop Real Est Inv Trust. What price target have analysts set for NWH.UN? 4 Wall Street analysts have issued 12 month target prices for NorthWest Health Prop Real Est Inv Trust's stock. Their forecasts range from C$11.00 to C$12.15. On average, they expect NorthWest Health Prop Real Est Inv Trust's share price to reach C$11.69 in the next twelve months. This suggests a possible upside of 5.8% from the stock's current price. View analysts' price targets for NorthWest Health Prop Real Est Inv Trust. Has NorthWest Health Prop Real Est Inv Trust been receiving favorable news coverage? Media headlines about NWH.UN stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NorthWest Health Prop Real Est Inv Trust earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about NorthWest Health Prop Real Est Inv Trust. Who are some of NorthWest Health Prop Real Est Inv Trust's key competitors? Some companies that are related to NorthWest Health Prop Real Est Inv Trust include Assura (AGR), Chartwell Retirement Residences (CSH.UN), Primary Health Properties (PHP), Impact Healthcare REIT (IHR) and Medicx Fund (MXF). View all competitors. Who are NorthWest Health Prop Real Est Inv Trust's key executives? NorthWest Health Prop Real Est Inv Trust's management team includes the following people: Mr. Paul Dalla Lana, Chairman & CEO (Age 52)Mr. Bernard W. Crotty, Pres & Trustee (Age 57)Mr. Shailen Chande CPA, CA, Chief Financial OfficerMr. Jan Krizan CFA, Managing Director of Germany (Age 50)Mr. Craig Douglas Mitchell BComm, EMBA, FCPA, Chief Exec. Officer of NorthWest Healthcare Properties Management What is NorthWest Health Prop Real Est Inv Trust's stock symbol? NorthWest Health Prop Real Est Inv Trust trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NWH.UN." How do I buy shares of NorthWest Health Prop Real Est Inv Trust? Shares of NWH.UN and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is NorthWest Health Prop Real Est Inv Trust's stock price today? One share of NWH.UN stock can currently be purchased for approximately C$11.05. How big of a company is NorthWest Health Prop Real Est Inv Trust? NorthWest Health Prop Real Est Inv Trust has a market capitalization of C$1.95 billion and generates C$376.12 million in revenue each year. NorthWest Health Prop Real Est Inv Trust employs 213 workers across the globe. What is NorthWest Health Prop Real Est Inv Trust's official website? The official website for NorthWest Health Prop Real Est Inv Trust is www.nwhp.ca. How can I contact NorthWest Health Prop Real Est Inv Trust? NorthWest Health Prop Real Est Inv Trust's mailing address is 284 King St E Suite 100, TORONTO, ON M5A 1K4, Canada. The company can be reached via phone at +1-416-3662000. This page was last updated on 7/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
